Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe Eosinophilic Gastroenteritis in a Crohn's Disease Patient Treated With Infliximab and Adalimumab.

× No keyword cloud information.

14 in total

1. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis.

Authors: A M Levy; K Yamazaki; V P Van Keulen; L J Burgart; W J Sandborn; S F Phillips; G M Kephart; G J Gleich; K M Leiferman
Journal: Am J Gastroenterol Date: 2001-05 Impact factor: 10.864

2. Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease.

Authors: Casper Steenholdt; Morten Svenson; Klaus Bendtzen; Ole Østergaard Thomsen; Jørn Brynskov; Mark Andrew Ainsworth
Journal: J Crohns Colitis Date: 2011-08-31 Impact factor: 9.071

Review 3. Eosinophilic gastroenteritis.

Authors: K J Kelly
Journal: J Pediatr Gastroenterol Nutr Date: 2000 Impact factor: 2.839

4. Wells' syndrome (eosinophilic cellulitis) secondary to infliximab.

Authors: Nicola Tugnet; Amgad Youssef; Andrew J Whallett
Journal: Rheumatology (Oxford) Date: 2011-10-22 Impact factor: 7.580

5. Delayed hypersensitivity reaction after initial dose of infliximab: a case report.

Authors: Anna Krajcovicova; Tibor Hlavaty; Zuzana Zelinkova; Juraj Letkovsky; Martin Huorka
Journal: Eur J Gastroenterol Hepatol Date: 2014-04 Impact factor: 2.566

Review 6. Eosinophilic gastroenteritis.

Authors: Seema Khan
Journal: Best Pract Res Clin Gastroenterol Date: 2005-04 Impact factor: 3.043

7. A previously unrecognized subgroup of "eosinophilic gastroenteritis". Association with connective tissue diseases.

Authors: K DeSchryver-Kecskemeti; R E Clouse
Journal: Am J Surg Pathol Date: 1984-03 Impact factor: 6.394

Review 8. Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab.

Authors: P Boura; A Sarantopoulos; I Lefaki; P Skendros; P Papadopoulos
Journal: Ann Rheum Dis Date: 2006-06 Impact factor: 19.103

9. Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases.

Authors: Margaret H Collins
Journal: Gastroenterol Clin North Am Date: 2014-03-19 Impact factor: 3.806

10. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

Authors: S Dubucquoi; A Janin; O Klein; P Desreumaux; P Quandalle; A Cortot; M Capron; J F Colombel
Journal: Gut Date: 1995-08 Impact factor: 23.059

5 in total

1. Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab.

Authors: Tanja Grandinetti; Luc Biedermann; Christian Bussmann; Alex Straumann; Petr Hruz
Journal: Dig Dis Sci Date: 2019-04-13 Impact factor: 3.199

2. Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population.

Authors: Hillary Moore; Joshua Wechsler; Carrie Frost; Elizabeth Whiteside; Robert Baldassano; Jonathan Markowitz; Amanda B Muir
Journal: J Pediatr Gastroenterol Nutr Date: 2021-03-01 Impact factor: 3.288

Review 3. Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors: Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal: World J Gastroenterol Date: 2019-08-21 Impact factor: 5.742

4. Eosinophilic Enteritis: A Delayed Diagnosis.

Authors: Ankita Munjal; Abdulhameed Al-Sabban; Kathryn Bull-Henry
Journal: J Investig Med High Impact Case Rep Date: 2017-10-03

5. Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist.

Authors: Sho Hayashida; Shunsuke Sato; Yuji Shimada; Hironori Tsuzura; Yuji Ikeda; Sho Takahashi; Sho Sato; Nozomi Amano; Ayato Murata; Akihito Nagahara; Takuya Genda
Journal: Intern Med Date: 2020-08-15 Impact factor: 1.271

5 in total